Department of Biochemistry and Microbiology, Faculty of Science and Agriculture, University of Fort Hare, Private Bag X1314, Alice 5700, South Africa.
Gastroenterol Res Pract. 2013;2013:259457. doi: 10.1155/2013/259457. Epub 2013 Apr 24.
Rapid diagnosis and treatment of Helicobacter pylori (H. pylori) presents a challenge. We aimed at investigating the presence of H. pylori, susceptibility profile, and associated mutations in an effort to validate the effectiveness of GenoType HelicoDR assay in H. pylori typing in our environment. Two hundred and fifty-four biopsy specimens were cultured and DNA extracted from seventy-eight positive cultures using the Qiagen DNA extraction kit. The GenoType Helico DR which employs reverse hybridisation was used to confirm the presence of H. pylori, determination of its susceptibility to antimicrobials, and detection of mutations conferring resistance to clarithromycin and fluoroquinolones. The organism was isolated from 168/254 (66.1 %) of the specimens by culture. Of the 78 strains used for further investigation, 12/78 (15.38%) were resistant to clarithromycin while 66/78 (84.61%) were susceptible. For fluoroquinolone, 70/78 (89.74%) strains were susceptible while 8 (10.26%) were resistant. Mutations were observed in 17 strains with A2147G being the most prevalent; A2146C and D91N were the least. The reverse hybridisation assay is an easy and fast technique in confirming the presence of H. pylori, its antimicrobial profile, and associated mutations. Analysis regarding the suitability of this assay for H. pylori typing is warranted in other regions.
幽门螺杆菌(H. pylori)的快速诊断和治疗是一个挑战。我们旨在调查 H. pylori 的存在、药敏谱和相关突变,以验证 GenoType HelicoDR 检测在我们环境中用于 H. pylori 分型的有效性。从 78 个阳性培养物中提取 DNA 用 Qiagen DNA 提取试剂盒。采用反向杂交的 GenoType HelicoDR 用于确认 H. pylori 的存在、确定其对抗微生物药物的敏感性以及检测导致克拉霉素和氟喹诺酮耐药的突变。通过培养从 254/254 个标本中分离出该生物体 168/254(66.1%)。进一步研究的 78 株菌株中,12/78(15.38%)对克拉霉素耐药,66/78(84.61%)敏感。对于氟喹诺酮,70/78(89.74%)株敏感,8 株(10.26%)耐药。17 株菌株中观察到突变,A2147G 最为常见;A2146C 和 D91N 最少。反向杂交检测是一种简单、快速的技术,可用于确认 H. pylori 的存在、其药敏谱和相关突变。有必要在其他地区分析这种检测方法是否适合 H. pylori 分型。